Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Early HCV RNA values after interferon predict response

T E Wiley1, L Briedi, N Lam

  • 1Department of Medicine, University of Illinois at Chicago Medical Center, 60612-7323, USA.

Digestive Diseases and Sciences
|October 28, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From the clinic to the lab and back: an interview with Professor Eric Wai-choi Tse.

Hong Kong medical journal = Xianggang yi xue za zhi·2025
Same author

Canadian Surgery Forum: Abstracts of presentations to the Annual Meetings of the Canadian Association of Bariatric Physicians and Surgeons, Canadian Association of General Surgeons, Canadian Association of Thoracic Surgeons, Canadian Hepato-Pancreato-Biliary Association, Canadian Society of Surgical Oncology, Canadian Society of Colon and Rectal Surgeons, Vancouver, BC, Sept. 17-21, 2013.

Canadian journal of surgery. Journal canadien de chirurgie·2025
Same author

Cardiovascular risk in bus drivers.

Hong Kong medical journal = Xianggang yi xue za zhi·2020
Same author

Identification of CASZ1 NES reveals potential mechanisms for loss of CASZ1 tumor suppressor activity in neuroblastoma.

Oncogene·2016
Same author

An assessment of racial differences in the upper limits of normal ALT levels in children and the effect of obesity on elevated values.

Pediatric obesity·2016
Same author

Esophageal stenting for treatment of refractory benign esophageal strictures in dogs.

Journal of veterinary internal medicine·2013
Same journal

Upward Mobility: How Mobile Endoscopy Revolutionized Endoscopic Practice in the Developing World.

Digestive diseases and sciences·2026
Same journal

Hematologic and Inflammatory Biomarker-Based Prognostic Assessment in Acute Pancreatitis: The Role of CRP, Procalcitonin, and CRP/Albumin Ratio.

Digestive diseases and sciences·2026
Same journal

Prevalence and Impact of Protein-Calorie Malnutrition in Hospitalized Patients with Steatotic Liver Disease.

Digestive diseases and sciences·2026
Same journal

Development and Validation of a Crotonylation-Related Prognostic Risk Model for Cholangiocarcinoma Based on Integrative Transcriptome Analysis.

Digestive diseases and sciences·2026
Same journal

Cardiac Arrests During Inpatient Gastrointestinal Endoscopic Procedures: A United States Nationwide Assessment.

Digestive diseases and sciences·2026
Same journal

Standardizing Transition of Care for Adolescents with Inflammatory Bowel Disease: The Need for a Unified Approach.

Digestive diseases and sciences·2026
See all related articles

Early hepatitis C virus (HCV) RNA measurements after 48 hours of interferon-alpha (IFN-alpha) treatment can predict long-term response in HCV patients. This finding aids in optimizing antiviral therapy and patient outcomes.

Area of Science:

  • Hepatology
  • Virology
  • Pharmacology

Background:

  • Hepatitis C virus (HCV) infection is a significant global health concern.
  • Interferon-alpha (IFN-alpha) is a standard treatment for HCV, but predicting treatment response can be challenging.

Purpose of the Study:

  • To evaluate if early HCV RNA levels at 48 hours post-IFN-alpha administration predict treatment response.
  • To assess the correlation between early viral kinetics and long-term outcomes in HCV patients.

Main Methods:

  • Twenty-three HCV patients received standard IFN-alpha (3 million IU) therapy.
  • HCV RNA levels were quantified using branched-chain (b-)DNA analysis at baseline, 24, and 48 hours, and at 1, 3, and 6 months.
  • Polymerase chain reaction (PCR) was used for further viral load assessment in select patients.

Related Experiment Videos

Main Results:

  • Mean HCV RNA levels decreased significantly at 24 hours but increased by 48 hours post-IFN-alpha.
  • HCV RNA levels at 48 hours were predictive of viral load at 1 and 6 months.
  • Patients negative for HCV RNA by bDNA at 48 hours showed a higher likelihood of sustained virologic response.

Conclusions:

  • Early HCV RNA quantification at 48 hours after initial IFN-alpha dose is a reliable predictor of treatment response.
  • This early virologic marker can guide therapeutic decisions and patient management in HCV treatment.